Skip to content
drillr.ai
Sign up

NVO

Novo Nordisk A/S

NYSE · Healthcare · Drug Manufacturers - General · DK

$46.62
−1.87%
Ask drillr

  • Jul 31, 2026, 17:45 UTC

    Pfizer is pursuing a position in the obesity-drug market through its acquisition of Metsera and a broader GLP-1 pipeline.

    Source:

  • Jul 28, 2026, 11:55 UTC

    Novo Nordisk achieved a profit margin of 33.1% in the 2026 Fortune Global 500, the highest among pharmaceutical companies.

    Source:

  • Jul 15, 2026, 10:29 UTC

    SOL Group agrees to acquire Danish Novis Medical Co., Ltd.

    Source:

  • Jul 15, 2026, 00:45 UTC

    Eli Lilly launched its oral weight-loss drug Foundayo in April 2026.

    Source:

  • Jul 14, 2026, 14:42 UTC

    Former Akero Therapeutics executives, backed by Fairmount, launch a new publicly traded immunology company centered around a long-acting immunology drug from a Chinese firm.

    Source:

  • Jul 2, 2026, 11:39 UTC

    Novo Holdings is backing an Italian fund to support drug startups outside Denmark.

    Source:

  • Jun 30, 2026, 08:30 UTC

    The Trump administration negotiated a monthly $245 price for GLP-1 drugs in Medicare and Medicaid with Eli Lilly and Novo Nordisk, contingent on private Medicare insurers covering the drugs for all uses with a $50 copay.

    Source:

  • Jun 29, 2026, 23:59 UTC

    York County Council unanimously passed the second reading of a $1.5 billion incentive agreement with a global biopharmaceutical company (Project Palmetto Rock) for a corporate headquarters and manufacturing facility.

    Source:

  • Jun 28, 2026, 14:00 UTC

    Novo Nordisk A/S (B Shares) ADRhedged disclosed a quarterly dividend of $0.7667 per share, paid on June 23rd to shareholders of record on June 16th, representing an annualized dividend of $3.07 and a yield of 11.7%.

    Source:

  • Jun 25, 2026, 13:10 UTC

    Lexaria Bioscience Corp. began dosing on schedule on June 14, 2026, for its Human Pilot Study #7 (GLP-1-H26-7) evaluating two oral DehydraTECH-semaglutide compositions against Novo Nordisk's Wegovy tablets.

  • Jun 18, 2026, 19:51 UTC

    Novo Nordisk confirmed a data breach where hackers spent two months inside its systems and stole clinical trial data and AI models.

    Source:

  • Jun 15, 2026, 11:17 UTC

    Novo Nordisk disclosed that hackers breached its IT systems and accessed personal data.

    Source:

  • Jun 11, 2026, 15:30 UTC

    Novo Nordisk A/S identified an IT security incident involving unauthorized access to a limited number of internal IT systems.

    Source:

  • Jun 9, 2026, 13:35 UTC

    AstraZeneca reported encouraging mid-stage trial results for its experimental weight-loss pill elecoglipron, showing 11.8% weight loss after 36 weeks.

    Source:

  • Jun 2, 2026, 21:43 UTC

    Cigna drops coverage of GLP-1 obesity drugs for its own employees effective July 1.

    Source:

  • Jun 1, 2026, 11:17 UTC

    Novo Nordisk initiated a share repurchase programme on 6 May 2026 as part of a larger programme of up to DKK 15 billion over 12 months from 4 February 2026.

    Source:
← PreviousPage 2